A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(R)) in client-owned dogs with atopic dermatitis - Cosgrove, S B; Wren, J A; Cleaver, D M (Vet Dermatol, 2013)
e141–142